ARAY News 9.01 Accuray Incorporated (ARAY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Accuray Incorporated (ARAY) 9.01 $ARAY

ABIOMED's Impella RP Bags CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 5:50PM CDT
Shares of ABIOMED climbed 2.8% following the announcement last week, to close at $24.48 till the last closing date.

Is A Short Squeeze Ahead for Accuray (ARAY)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:47AM CDT
Is A Short Squeeze Ahead for Accuray (ARAY)?

Accuray Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 1:50PM CDT
Accuray's year-over-year loss narrowed primarily due to robust top-line improvement of 20% from the year-ago period.

Health Care Sector Stocks under Review -- Research on Wright Medical, Globus Medical, Intuitive Surgical, and Accuray
PR Newswire - Tue Apr 15, 10:03AM CDT
The trading session on Monday, April 14, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,173.24, up 0.91% and the NASDAQ Composite closed at 4,022.69, up 0.57%. The S&P 500 finished the session 0.82% higher at 1,830.61. The gains were broad based as all the ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has lost 1.86% in the last three months. Investor-Edge has initiated coverage on the following equities: Wright Medical Group Inc. (NASDAQ: WMGI), Globus Medical Inc. (NYSE: GMED), Intuitive Surgical Inc. (NASDAQ: ISRG) and Accuray Inc. (NASDAQ: ARAY). Free technical research on WMGI, GMED, ISRG and ARAY can be downloaded upon signing up at:

Will Obamacare Lead to a Medical Device Innovation Revolution?
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 13, 11:31AM CDT
The first year of Obamacare enrollment is officially in the books, and more than 7 million people enrolled for health insurance on a state or federally run Obamacare exchange. This figure more or less matches projected enrollment targets from the...

Accuray to Report Financial Results for Third Quarter Fiscal 2014
GlobeNewswire - Thu Apr 10, 3:35PM CDT
Accuray Incorporated (Nasdaq:ARAY) announced today that it will report results for its third quarter of fiscal 2014, ended March 31, 2014 on Wednesday, April 30, 2014 after the market closes.

Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Accuray Incorporated (NASDAQ: ARAY), Cerus Corporation (NASDAQ: CERS), Galena Biopharma, Inc. (NASDAQ: GALE), and ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

The European CyberKnife Center Munich is celebrating its 5,000th patient treatment using the CyberKnife(R) System
PR Newswire Europe - Mon Apr 07, 7:31AM CDT
-- Where experience and state-of-the-art technology meet

The European CyberKnife Center Munich is celebrating its 5,000th patient treatment using the CyberKnife® System
CNW Group - Mon Apr 07, 7:30AM CDT
Where experience and state-of-the-art technology meet

Accuray Identifies EIMEA Region as Growth Territory
PR Newswire Europe - Thu Apr 03, 7:31AM CDT
- Acceptance of Accuray technologies in key markets adds to company's global market share

Accuray Up 26.4% Since SmarTrend Uptrend Call (ARAY)
Comtex SmarTrend(R) - Mon Mar 31, 5:00PM CDT
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 5 months, Accuray has returned 26.40% as of today's recent price of $9.60.

Accuray Incorporated's CyberKnife(R) M6(TM) System Receives Shonin Approval
PR Newswire Europe - Thu Mar 27, 7:31AM CDT
-- Latest CyberKnife technology now available in Japan

Accuray Incorporated's CyberKnife® M6(TM) System Receives Shonin Approval
CNW Group - Thu Mar 27, 7:31AM CDT
Latest CyberKnife technology now available in Japan

Global Radiation Therapy Equipment Market 2014-2018: Key Regions, Key Vendors and Key Market Trends
M2 - Wed Mar 26, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2bjnr/global_radiation) has announced the addition of the "Global Radiation Therapy Equipment Market 2014-2018" report to their offering. Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer. It involves delivering high doses of radiation consisting of photons, electrons or gamma rays to kill cancer cells and reduce the rate at which the cancerous cells multiply by damaging the DNA inside the tumor cells. Radiation therapy is used to treat cancers of the head and neck, bladder, and lung as well as Hodgkin's disease. Radiation therapy can be administered in several ways. The type of therapy prescribed by oncologists depends on factors such as the type of cancer, the stage of the cancer, the size of the tumor, the position of the tumor in the body, the age of the patient, and the patient's medical history. Radiation therapy can either be given independently or in conjunction with other cancer treatments such as surgery and chemotherapy. The analysts forecast the Global Radiation Therapy Equipment market will grow at a CAGR of 6.04 percent over the period 2013-2018. Key Regions - Americas - EMEA - APAC Key Vendors - Accuray Inc. - Elekta AB - Siemens Healthcare - Varian Medical Systems Inc. Other Prominent Vendors - Best Theratronics Ltd. - Brainlab AG - C.R. Bard Inc. - Eckert & Ziegler BEBIG - GE Healthcare Ltd. - Hitachi America Ltd. - Ion Beam Applications SA - Philips Healthcare - RaySearch Laboratories AB Key Market Drivers - Increase in Aging Population. - For a full, detailed list, view our report. For more information visit http://www.researchandmarkets.com/research/v2..._radiation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

20.5% Return Seen to Date on SmarTrend Accuray Call (ARAY)
Comtex SmarTrend(R) - Mon Mar 24, 11:06AM CDT
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 5 months, Accuray has returned 20.47% as of today's recent price of $9.15.

Medical Robots Market by Type & Application - Global Forecasts to 2018 for the $1,781 Million Market
M2 - Fri Mar 21, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwj8xd/medical_robots) has announced the addition of the "Medical Robots Market by Type (Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton) & Application (Orthopedic, Neurology, Laparoscopy)- Global Forecasts to 2018" report to their offering. The medical robotics market was valued at $1,781 million in 2013 and is expected to reach $3,764 million by 2018, growing at a CAGR of 16.1% from 2013 to 2018 Over the years, the demand for medical robots has increased significantly. This is due to the paradigm shift in the healthcare industry where emphasis is being laid on minimally invasive surgeries through the use of robots. The global medical robot market is categorized into five broad segments - surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and others. Based on applications, the medical robots market comprises the following segments - neurology, orthopedics, laparoscopy, special education, and other areas. . The hospital and pharmacy robots segment is the fastest-growing segment of the medical robotics market. The increasing demand for telemedicine robots is likely to propel the growth of this market. Along with this, technological developments and increasing adoption of newer technologies by hospitals are some factors that are propelling the demand for hospital and pharmacy robots. The other major segment under hospital and pharmacy robots is the i.v. robots segment. i.v. robots are dispensing robots used in hospitals and pharmacies to accurately compound drug mixtures. These robots are used to administer safe, accurate, efficient, cost-effective, and ready-to-administer IV admixtures. Factors such as an aging population, increasing spending power of the middle-class population, increasing number of private sector hospitals, advancements in endoscopic technologies, and expansions of rural healthcare facilities are also going to play a pivotal role in boosting the demand for medical robotics in the Asian region. China and Japan will be the focal point for the growth of medical robotics in the Asian market. Countries such as Singapore and Thailand are also expected to witness growth in this sector, owing to increasing government support. North America and Europe are both likely to witness an increasing demand for medical robotics owing to technological advancements as well as increased government support in both the geographies. Scope of the Report Segment - Surgical Robots -- Orthopedic Surgical Robots -- Neurological Surgical Systems -- Laparoscopy Robotic Systems -- Steerable Robotic Catheters - Rehabilitation Robots -- Assistive Robots -- Prosthetics -- Orthotics -- Therapeutic Robots -- Exoskeleton Robotic Systems - Non-Invasive Radio surgery Robots - Hospital and Pharmacy Robots -- Telemedicine Robots -- I.V. Robots -- Pharmacy Robots - Others Application - Neurology - Orthopedics - Laparoscopy - Special Education - Others Companies Mentioned - Accuray, Inc. - Hansen Medical, Inc. - Health Robotics S.R.L. - Intuitive Surgical Inc. - Mako Surgical Corp. - Mazor Robotics Ltd. - Medrobotics Corporation - Or Productivity Plc - Renishaw Plc - Titan Medical Inc. For more information visit http://www.researchandmarkets.com/research/mw...cal_robots

Accuray Honored for Delivering 'World-Class' Customer Service
PR Newswire - Tue Mar 18, 7:30AM CDT
Accuray Incorporated (Nasdaq: ARAY), announced today it has received the NorthFace ScoreBoard AwardSM from Omega Management Group Corp. in recognition of achieving excellence in customer service and support in 2013. This is the third year in a row Accuray has received this award. Since 2000, the award has been presented annually to companies who, as rated solely by their own customers, exceeded expectations in customer satisfaction during the prior calendar year. Omega is an expert in customer experience management (CEM) strategy, and helps companies boost revenue and profits by consistently exceeding customer expectations for service quality.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 54

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 250

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 106

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 82

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 176

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 106

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 103

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 0

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 359

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Marjorie Taylor Greene's Diverse Portfolio Emphasizes Growth

Updated Category News Views 243

Marjorie Taylor Greene's Investment Choices Marjorie Taylor Greene, a well-known congressional representative, is making headlines lately with her recent stock investments. Reports indicate that her investment decisions reflect a strong interest in diverse sectors, including technology, healthcare, and logistics. This varied approach highlights her strategic thinking as...

Continue Reading
RBB Bancorp's Incredible Third Quarter Gains and Dividend

Updated Category News Views 178

RBB Bancorp: A Review of Stellar Financial Performance RBB Bancorp, alongside its subsidiaries, has recently announced impressive financial results for the quarter ended September 30, 2025. In an era where financial stability is paramount, RBB Bancorp (NASDAQ:RBB) emerged with promising metrics indicating solid progress. Key Financial Highlights for Q3 2025 Net income...

Continue Reading
Hancock Whitney to Share Q3 2024 Results and Insights Soon

Updated Category News Views 69

Exciting News from Hancock Whitney Corporation Hancock Whitney Corporation (Nasdaq: HWC) is about to share its financial performance for the third quarter of 2024. This announcement will take place after the market closes, paving the way for an insightful conference call with both analysts and investors. Details on Financial Results and Conference Call The expected...

Continue Reading
GunsAmerica Reinforces Leading Role in Safe Online Firearm Sales

Updated Category News Views 229

GunsAmerica Reinforces Leading Role in Safe Online Firearm Sales GunsAmerica stands at the forefront of the online firearm marketplace, continually evolving to ensure the utmost safety and security for its users. The platform has earned a stellar reputation over its impressive 28-year history by prioritizing secure firearm transactions and implementing robust measures...

Continue Reading
Acrivon Therapeutics Pushes Ahead with ACR-2316 Trials

Updated Category News Views 70

Exciting Milestone in Oncology Trials Acrivon Therapeutics, Inc. has recently reached a significant milestone by dosing its first patient in the Phase 1 clinical trial of ACR-2316. This innovative WEE1/PKMYT1 inhibitor was developed using Acrivon’s advanced AP3 platform, which accelerates the discovery and design of effective cancer treatments. The progress marks a...

Continue Reading